Cytori Therapeutics (United States)

Cytori Therapeutics (United States)

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Cytori Therapeutics (United States), United States, covering academic research published from 2005 to 2018. Read More.


Open Access Percentage

25%


Total
Publications

56


Total Open
Publications

14


Total
Citations

5.6K


Open Access
Percentage

25%


Total
Publications

56


Total Open
Publications

14


Total
Citations

5.6K

Wikipedia

Website

download

Breakdown

12% 5% 9% 74%

Publisher Open

12%

Both

5%

Other Platform Open

9%

Closed

74%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20052006200720082009201020112012201320142015201620172018

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

00.511.522.533.544.555.566.57Total Publications
20052006200720082009201020112012201320142015201620172018

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

2

Hybrid 0%

0

No Guarantees 80%

8

Other Platform Open

Other Internet 63%

5

Domain 25%

2

Institution 13%

1

Public 13%

1

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

DOI
Other Internet
5
PubMed Central
Domain
2
Figshare
Public
1
aecid.es OAI-PMH Repository
Institution
1
1 / 1

Data updated 18 August 2025

Share

Share

Share